173 related articles for article (PubMed ID: 27221946)
1. Alteration of Leptin and Adiponectin in Multistep Colorectal Tumorigenesis.
Name N; Boonpipattanapong T; Palanusont A; Maneechay W; Sangkhathat S
Asian Pac J Cancer Prev; 2016; 17(4):Page. PubMed ID: 27221946
[TBL] [Abstract][Full Text] [Related]
2. Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients.
Kumor A; Daniel P; Pietruczuk M; Małecka-Panas E
Int J Colorectal Dis; 2009 Mar; 24(3):275-81. PubMed ID: 18979105
[TBL] [Abstract][Full Text] [Related]
3. Plasma adiponectin, visfatin, leptin, and resistin levels and the onset of colonic polyps in patients with prediabetes.
Deng L; Zhao X; Chen M; Ji H; Zhang Q; Chen R; Wang Y
BMC Endocr Disord; 2020 May; 20(1):63. PubMed ID: 32393372
[TBL] [Abstract][Full Text] [Related]
4. Interaction between adiponectin and leptin influences the risk of colorectal adenoma.
Yamaji T; Iwasaki M; Sasazuki S; Tsugane S
Cancer Res; 2010 Jul; 70(13):5430-7. PubMed ID: 20516125
[TBL] [Abstract][Full Text] [Related]
5. Association between pre-diagnostic circulating adipokines and colorectal cancer and adenoma in the CLUE II cohort.
Marrone MT; Lu J; Visvanathan K; Joshu CE; Platz EA
Cancer Causes Control; 2021 Aug; 32(8):871-881. PubMed ID: 33999316
[TBL] [Abstract][Full Text] [Related]
6. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of serum adipokine levels in colorectal cancer patients.
Guadagni F; Roselli M; Martini F; Spila A; Riondino S; D'Alessandro R; Del Monte G; Formica V; Laudisi A; Portarena I; Palmirotta R; Ferroni P
Anticancer Res; 2009 Aug; 29(8):3321-7. PubMed ID: 19661351
[TBL] [Abstract][Full Text] [Related]
8. Expression of IGF-1R in colorectal polyps and its role in colorectal carcinogenesis.
Shan HB; Zhang R; Li Y; Xu GL; Luo GY; Gao XY; Yang HL
Technol Cancer Res Treat; 2011 Aug; 10(4):381-9. PubMed ID: 21728395
[TBL] [Abstract][Full Text] [Related]
9. Association between post-treatment circulating biomarkers of inflammation and survival among stage II-III colorectal cancer patients.
Hua X; Kratz M; Malen RC; Dai JY; Lindström S; Zheng Y; Newcomb PA
Br J Cancer; 2021 Sep; 125(6):806-815. PubMed ID: 34230610
[TBL] [Abstract][Full Text] [Related]
10. Involvement of adiponectin in early stage of colorectal carcinogenesis.
Tae CH; Kim SE; Jung SA; Joo YH; Shim KN; Jung HK; Kim TH; Cho MS; Kim KH; Kim JS
BMC Cancer; 2014 Nov; 14():811. PubMed ID: 25370174
[TBL] [Abstract][Full Text] [Related]
11. Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer.
Nakajima TE; Yamada Y; Hamano T; Furuta K; Matsuda T; Fujita S; Kato K; Hamaguchi T; Shimada Y
Cancer Sci; 2010 May; 101(5):1286-91. PubMed ID: 20331631
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin levels in patients with colorectal cancer and adenoma: a meta-analysis.
An W; Bai Y; Deng SX; Gao J; Ben QW; Cai QC; Zhang HG; Li ZS
Eur J Cancer Prev; 2012 Mar; 21(2):126-33. PubMed ID: 21960184
[TBL] [Abstract][Full Text] [Related]
13. Plasma adiponectin and soluble leptin receptor and risk of colorectal cancer: a prospective study.
Song M; Zhang X; Wu K; Ogino S; Fuchs CS; Giovannucci EL; Chan AT
Cancer Prev Res (Phila); 2013 Sep; 6(9):875-85. PubMed ID: 23872505
[TBL] [Abstract][Full Text] [Related]
14. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
[TBL] [Abstract][Full Text] [Related]
15. Global and targeted serum metabolic profiling of colorectal cancer progression.
Long Y; Sanchez-Espiridion B; Lin M; White L; Mishra L; Raju GS; Kopetz S; Eng C; Hildebrandt MAT; Chang DW; Ye Y; Liang D; Wu X
Cancer; 2017 Oct; 123(20):4066-4074. PubMed ID: 28640361
[TBL] [Abstract][Full Text] [Related]
16. Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention Trial.
Bobe G; Murphy G; Rogers CJ; Hance KW; Albert PS; Laiyemo AO; Sansbury LB; Lanza E; Schatzkin A; Cross AJ
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1441-52. PubMed ID: 20501764
[TBL] [Abstract][Full Text] [Related]
17. Comparison of colorectal neoplastic polyps and adenocarcinoma with regard to NLR and PLR.
Emir S; Aydin M; Can G; Bali I; Yildirim O; Öznur M; Yildiz ZD; Sözen S; Gürel A
Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3613-8. PubMed ID: 26502851
[TBL] [Abstract][Full Text] [Related]
18. Serum adiponectin levels and tissue expression of adiponectin receptors are associated with risk, stage, and grade of colorectal cancer.
Gialamas SP; Petridou ET; Tseleni-Balafouta S; Spyridopoulos TN; Matsoukis IL; Kondi-Pafiti A; Zografos G; Mantzoros CS
Metabolism; 2011 Nov; 60(11):1530-8. PubMed ID: 21632074
[TBL] [Abstract][Full Text] [Related]
19. The relationship between serum adiponectin and resistin levels, insulin resistance and colorectal adenomas.
Demir N; Ahıshalı E; Dolapçıoğlu C; Ercan Ş; Orçun Kaptanağası A; Dabak R; Yücel N; Sargın M; Uygur Bayramiçli O
Turk J Gastroenterol; 2015 Jan; 26(1):20-4. PubMed ID: 25698266
[TBL] [Abstract][Full Text] [Related]
20. Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer.
Otake S; Takeda H; Fujishima S; Fukui T; Orii T; Sato T; Sasaki Y; Nishise S; Kawata S
World J Gastroenterol; 2010 Mar; 16(10):1252-7. PubMed ID: 20222170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
